TokenPost·
Arvinas Starts ARV-6723 Dosing, Reports $558.9 Million in Liquidity
Arvinas expects initial monotherapy data for ARV-6723 in the second half of 2027, while ARV-393 data are planned for a December hematology meeting.
More news
- TokenPostYieldMax Declares $0.3242 Weekly Distribution for YRAM ETF
- TokenPostPolymarket Midterm House Seat Markets Put Two GOP Outcomes at 28%
- TokenPostJetBlue Raises First-Bag Fees to $70 During Peak Travel Periods
- The BlockFormer Sen. Sherrod Brown defeats Jon Husted, dealing a blow to crypto PAC Fairshake
- Crypto BriefingSolana co-founder Anatoly Yakovenko tells data centers to pivot to crypto
- TokenPostYieldMax Lowers GPTY Weekly Distribution to $0.2433 Per Share